Invention Grant
- Patent Title: Compounds for treatment of neurodegenerative diseases
- Patent Title (中): 用于治疗神经变性疾病的化合物
-
Application No.: US11120502Application Date: 2005-05-03
-
Publication No.: US07705017B2Publication Date: 2010-04-27
- Inventor: Christopher J. Cummings , David A. Lowe , William C. Ripka
- Applicant: Christopher J. Cummings , David A. Lowe , William C. Ripka
- Applicant Address: US MA Watertown
- Assignee: En Vivo Pharmaceuticals, Inc.
- Current Assignee: En Vivo Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Edwards Angell Palmer & Dodge LLP
- Agent Elizabeth Spar; Kathleen Williams
- Main IPC: A61K31/47
- IPC: A61K31/47 ; C07D213/02

Abstract:
The present invention relates to a class of small molecule hydroxamic acid compounds capable of inhibiting histone deacetylases (HDACs). The present invention also relates to methods of preparation of hydroxamic acid HDAC inhibitor compounds of the invention, which are N-substituted-1,2,3,4-tetrahydroisoquinoline hydroxamic acid derivatives, and their incorporation into pharmaceutical compositions and methods of administration. The present invention also relates to N-substituted-1,2,3,4-tetrahydroisoquinoline hydroxamic acid derivatives, which may be prepared as a hydroxamic acid HDAC inhibitor compound library that can be utilized in screening methods known in the art.
Public/Granted literature
- US20060004041A1 Compounds for treatment of neurodegenerative diseases Public/Granted day:2006-01-05
Information query